The novel anti-inflammatory cytokine, IL-35 (consisting of EBI3 and IL-12A protein subunits), is produced at infection sites by M2 macrophages or Foxp3− Treg cells (iTr(35)) and this cytokine counters both IL-17A and Th17 cell activity during infection [16]. Here, IL17A is linked to infection.